tbuckley/cabot-search huggingface dataset:
A Phase II Trial of FM (Oral Fludarabine and Mitoxantrone) Chemotherapy Followed by Yttrium 90 (90Y) Ibritumomab Tiuxetan (Zevalin) for Previously Untreated Follicular Lymphoma (FL) Patients.
Authors: Pier Luigi Zinzani, Monica Tani, Vittorio Stefoni, Lapo Alinari, Enrica Marchi, Mariapaola Fina, Michele Baccarani
Journal: Blood (2005)
Hybridomas in Biotechnology and Medicine Course
Journal: JNCI Journal of the National Cancer Institute (1984)

Hybridomas in Biotechnology and Medicine Course Get access JNCI: Journal of the National Cancer Institute, Volume 72, Issue 1, January 1984, Page 200, https://doi.org/10.1093/jnci/72.1.200-a Published: 01 January 1984
THE RED-LIGHT TREATMENT OF SMALLPOX.
Journal: JAMA (1905)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Traveler's Amnesia
Authors: Harold H. Morris
Journal: JAMA (1987)

Three neuroscientists traveled on different occasions from New York to Europe to attend scientific meetings. In an attempt to minimize "jet lag," they all took triazolam, 0.5 mg, during the flight. In addition to the medication, they also consumed ethyl alcohol to a variable degree, none to clinical intoxication. All three experienced an episode of anterograde amnesia that lasted several hours. In two of the individuals, neurologists associated with them did not detect any memory disturbance at the time. These episodes of transient global amnesia were evidently secondary to the triazolam or the combination of triazolam and ethyl alcohol. These episodes suggest caution if using this medication to avoid jet lag, especially if ethyl alcohol will be consumed. (<i>JAMA</i>1987;258:945-946)
Medical Organization
Journal: JAMA (1905)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Hepatology Highlights
Authors: Nidhi Jalan‐Sakrikar, Robert E. Schwartz, Muhammad Amir, Joel Wedd, Joseph F. Pisa, Robert S. Brown, Nicholas W. Russo, Ravi S. Vora, Alyson Kaplan, Russell Rosenblatt, Amaia Navarro‐Corcuera, Enis Kostallari, Petra Hirsova
Journal: Hepatology (2020)
Keeping up with Cancer
Journal: CA A Cancer Journal for Clinicians (1957)

Smoking and Bronchial EpitheliumChanges in the tracheobronchial trees of 117 autopsied patients were studied histologically.Of this group, thirty-four had died of bronchogenic carcinoma and all were cigarette smokers.The remainder died of other causes, and sixteen had never smoked.twenty had smoked less than one pack a day.and forty-seven more than one pack a day.More than 80,000 histoloi@ical examinations were made to correlate basal-cell hyperplasia.stratification, squamous metaplasia, and carcinoma in situ with the smoking habits.These epithelial changes were least fre quent in the group that never smoked regularly, with a progressive increase in the moderateand heavy smokers.The most extensive changes were found in those who had diedof lungcancer.These findings are fully consistent with the hypothesis that inhalants, such as certain dusts and vapors as uranium and chrom ate dusts, general air pollution, and cig arette smoke, are important factors in the causation of bronchogen ic carcinoma.The findings are also fully consistent with the theory that cigarette smoking is an important factor in the causation of bronchogenic carcinoma..luerhach, 0.
Highlights
Journal: JAMA Cardiology (2019)

Anatomical scoring systems for coronary artery disease complexity, such as the SYNTAX (Synergy Between Percutaneous Coronary Intervention [PCI] With Taxus and Cardiac Surgery) score, are established risk assessment tools but are cumbersome to compute manually for large data sets.Using the Veterans Administration Clinical Assessment Reporting and Tracking Program, Valle and coauthors developed an anatomical scoring system for use with registry data, allowing automatic score calculation and association with clinical outcomes among patients undergoing revascularization.From 2010 through 2017, 50 226 patients were evaluated, with 34 322 undergoing PCI and 15 904 undergoing coronary artery bypass grafting.After adjustment, the highest tertile of anatomical complexity was associated with increased hazard of major adverse cardiovascular and cerebrovascular events for PCI but not for coronary artery bypass grafting.Author Audio Interview jamacardiology.com Safety and Efficacy of Antithrombotic Strategies in AF After PCI 747Antithrombotic treatment of patients with atrial fibrillation (AF) and coronary artery disease is a challenge in clinical practice, particularly those with acute coronary syndrome or percutaneous coronary intervention (PCI).Lopes and coauthors performed a network metaanalysis of 4 randomized clinical trials of antithrombotic regimens, including a total of 10 026 patients.Compared with vitamin K antagonist (VKA) plus dual antiplatelet therapy, a regimen of non-VKA oral anticoagulant plus P2Y 12 inhibitor was associated with less bleeding.Strategies omitting aspirin caused less bleeding without increase in ischemic events compared with those including aspirin.These results support use of non-VKA oral anticoagulant plus P2Y 12 inhibitor for high-risk patients.
Liver transplantation for hepatocellular carcinoma: The impact of human immunodeficiency virus infection—21 plus 13
Authors: René Adam, Eric Vibert, Jean-Charles Duclos-Vallee, Didier Samuel
Journal: Hepatology (2011)

The Model for End-Stage Liver Disease scores of their patients were low (median = 10, range = 10-13) in comparison with the scores of our patients (median = 15, range = 8-31). No patients in their series had a pretransplant alpha-fetoprotein serum level > 100 μg/L, whereas 6 of our 21 listed patients (28.5%) did. Also, only one of their patients (7.7%) had microvascular invasion, whereas the proportion was 50% (8/16) for our transplant patients. Finally, the CD4 cell count was >200/mL for all their patients, but for 6 of the 21 patients (28.5%) listed for liver transplantation in our series, the count was <200 cells/mL. Therefore, even if the results are comparable except for the absence of recurrence and dropout in their series, both differences can be explained by the higher HCC stage of our patients, their more altered liver function, and the higher impact of the HIV infection on their CD4 cell count. With the stricter selection criteria that Baccarani and Coll have applied for listing patients with HIV and HCC, they have confirmed that excellent results can be obtained for these patients. However, we should be careful about drawing definitive conclusions about patient selection from these two limited series. Predictive factors for tumor progression and recurrence must be better defined in this subgroup of patients, and combinations of therapies and more rigorous follow-up are advocated for improving the post–liver transplant results for HIV-infected patients with HCC. René Adam M.D., Ph.D.* §, Eric Vibert M.D.* ¶, Jean-Charles Duclos-Vallee M.D., Ph.D.* ¶, Didier Samuel M.D., Ph.D.* ¶, * Centre Hepato-Biliaire, Hôpital Paul Brousse Assistance Publique-Hôpitaux de Paris Villejuif, France, Unité 776, Institut National de la Santé et de la Recherche Médicale Villejuif, France, Unité 785, Institut National de la Santé et de la Recherche MédicaleVillejuif, France, § Unités Mixtes de Recherche en Santé 776 Université Paris-Sud Villejuif, France, ¶ Unités Mixtes de Recherche en Santé 785 Université Paris-Sud Villejuif, France.
ACTION OF THE PARATHYROID HORMONE
Journal: JAMA (1927)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Incorrect Painting Title and Omission of Copyright Information
Authors: Nicholas Downing, Joseph Ross
Journal: JAMA (2014)

individuals elected to purchase the test prior to its withdrawal 1 ) speaks to the desire of patients to empower themselves to understand their potential health risks.Furthermore, in the United States, the PGS is regulated as a diagnostic test, and thereby as a medical device, meaning that proof of clinical utility is generally not required for approval.In fact, the clinical utility of some diagnostic tests that are used widely today still remains uncertain.For instance, 2 recent reviews 2,3 attempted to determine the clinical utility of mammography for breast cancer screening, weighing the potential benefits and risks for women.Physicians, payers, and comparative effectiveness organizations can play an important role in limiting the use of diagnostic tests with low clinical utility, which will in turn limit overdiagnosis, overtreatment, and unnecessary medical costs. 4 Physicians routinely contextualize uncertainty about the benefits and risks of various medical interventions in an effort to promote informed decision making.Reintroducing the PGS, and allowing its use only in conjunction with a physician after its analytical validity has been established, would fit with today's regulatory standards.In addition, this would not only empower patients to explore their potential health risks, but also provide an important opportunity for physicians to contextualize the significant uncertainty about the product's clinical utility.
Four layer bandage compared with short stretch bandage for venous leg ulcers: systematic review and meta-analysis of randomised controlled trials with data from individual patients
Journal: BMJ (2009)

Objective To compare the effectiveness of two types of compression treatment (four layer bandage and short stretch bandage) in people with venous leg ulceration.Design Systematic review and meta-analysis of patient level data. Data sources Electronic databases (the Cochrane CentralRegister of Controlled Trials, the Cochrane Wounds Group Specialised Register, Medline, Embase, CINAHL, and National Research Register) and reference lists of retrieved articles searched to identify relevant trials and primary investigators.Primary investigators of eligible trials were invited to contribute raw data for re-analysis.Review methods Randomised controlled trials of four layer bandage compared with short stretch bandage in people with venous leg ulceration were eligible for inclusion.The primary outcome for the meta-analysis was time to healing.Cox proportional hazards models were run to compare the methods in terms of time to healing with adjustment for independent predictors of healing.Secondary outcomes included incidence and number of adverse events per patient.Results Seven eligible trials were identified (887 patients), and patient level data were retrieved for five (797 patients, 90% of known randomised patients).The four layer bandage was associated with significantly shorter time to healing: hazard ratio (95% confidence interval) from multifactorial model based on five trials was 1.31 (1.09 to 1.58), P=0.005.Larger ulcer area at baseline, more chronic ulceration, and previous ulceration were all independent predictors of delayed healing.Data from two trials showed no evidence of a difference in adverse event profiles between the two bandage types.Conclusions Venous leg ulcers in patients treated with four layer bandages heal faster, on average, than those of people treated with the short stretch bandage.Benefits were consistent across patients with differing prognostic profiles.
A Correction
Authors: Mr Darr, T Atkins, Lon Addiscott, S Aarons, A Ajax, Ariel Cycle, Mr Anderson, Glasgow Auti-Sixpence, Messrs Allen, Hanb Krys, C Branch, St Vincent, W Builoch, Rev Bndon; Beta, C Buttar, W Bruce, C Birmingham, Mr Bristow, Mr Briant, G Orowe, L Cobbett, W Campbel, A Clarke, Xrs Ooruwal', ; Oane, St Edmunds, G Casalis, J Collins, H Clogg, B Cuuinan, D Drew_ London, Miss Dendy, ; I Dunsmuir, G Elliott, Messrs Ereck, Co Fryer, F Foy, Rangoon Grafton, G Gill, W Gosse, G Graham-Smith, Cambridge Goldtborn, Mr Goadby, P London, M Griffitbh, G Gifford, Omeath Glenny, Mr Gomme, E Gowers, P Harrogate, Northampton Hichens, R Hebb, A Hart, C Hawthorne, J Hamilton, E Harrison, W Jones, J Johnston, Clifton On, Molton South, Mr King, ; Killick, J Keay, J Langston, ; Lett, G Livingsttm, Mr Lawrence, ; Liverpoql, Mr Logan, Mr Lloyd, J Mackenzie, London Merardy, Darmstadt Merck, C Mar, E Magennis, Mr Mann, R London, Hove Marsh, J Me Calfe, Btadford, ; Melaren, Dublin Montgomery, C Mr, I Iverpool.- O I R Isicbolson, Obstetrical Society, Messs Kega'l Paul, Paddy Power, Broadsta Rtaven, J Rs, London Russe'l, ', J Robertson
Journal: BMJ (1904)

JOEN FRYER (Dewsbury) writes: I bave just been reading the "summary" of the final rep)rt of tbe Royal Commis*ion appointed to inquire iuto the Subject of Vaecination, given in the reprint of the JBRITISH MEDICAL JOURNAL (Vaccination b'acts and Problems).I have a prec?8 or digest of evidence taken before a Committee of the House of Commons, on the Vaccination Act, I867.Can you tell me of a similar *prdcis or digest of the evidence given before the Royal Commission appointed in z889, whose report was issued in Augtist.z896?The precis or digest that I have gives a condensed report of each of the witnesses' evidence given before the Commission.%* There is unfortunately no such summary or digest.The evidence is contained verbatim in a series of large Blue Books, which with one exceptlon have a very good index.The exception-the Sixth Report- Is the largest and, in some respects.the most important of all, but the *want of an index makes it almost useless for purposes of reference, excepting to the most laborious student.As indicated at the end of the article referred to by our correspondent, the statement of dissent from the Commissioners' final report has been fully reviewed in the Transac- tion of the Epidemiological Society for 31896-7. ANSWERS,THERaPuTIrCs.-Weregret that we have not been able to obtain information as to the composition of the secret remedy in question.
ITALY
Journal: JAMA (1924)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Erratum for the Research Article: “Modulation of the sigma-1 receptor–IRE1 pathway is beneficial in preclinical models of inflammation and sepsis” by D. A. Rosen, S. M. Seki, A. Fernández-Castañeda, R. M. Beiter, J. D. Eccles, J. A. Woodfolk, A. Gaultier
Journal: Science Translational Medicine (2019)
Developmental Adhesions Affecting The Lower End Of The Ileum And The Colon.
Journal: JAMA (1913)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Neurofibromatosis Clue
Authors: Rebecca Voelker
Journal: JAMA (1998)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Antilymphoblastic globulin in renal transplant patients: no allergic reactions: a correction
Authors: S. N. Chou
Journal: JAMA (1995)

<h3>To the Editor.</h3> —The University of Minnesota wishes to correct the public record. An article appearing in the October 11, 1976, issue of<i>JAMA</i>entitled "Antilymphoblastic Globulin in Renal Transplant Patients: No Allergic Reactions"<sup>1</sup>incorrectly referred to Richard Condie as Richard Condie, PhD. Mr Condie did not possess, and to our best knowledge does not possess, a PhD degree or any degree beyond the baccalaureate. A recent federal indictment has named Mr Condie and others regarding unreported deaths of patients associated with administration of antilymphoblast globulin.<sup>2</sup>I can say that none of the unreported deaths occurred in the 50 patients reported in the<i>JAMA</i>article. <i>This letter was shown to Mr Condie, who declined to reply. At the time this request was made, Dr Chou was interim dean of the University of Minnesota Medical School</i>.—Ed.
Inhibition by -blockade of the ST segment elevation after acute myocardial infarction in man
Authors: L. J. PELIDES, D. S. REID, M. THOMAS, J. P. SHILLINGFORD
Journal: Cardiovascular Research (1972)

The changes in height and extent of the ST segment elevation after the administration of the β-blocking drug practolol to nine patients with acute myocardial infarction have been studied. In all the patients there was a reduction in the area of ST segment elevation recorded over the surface of the chest and in eight of the nine there was a reduction in the total height (ΣST) and mean height (ST) of the ST segment elevation. These findings are discussed in relation to (1) quantitating the extent and severity of the ischaemic lesion in man, and (2) the reduction in the extent and severity of the ischaemia by β-blockade.